Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilder, B. J.
Right arrow Articles by Hammond, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilder, B. J.
Right arrow Articles by Hammond, E. J.
NEUROLOGY 1983;33:1474
© 1983 American Academy of Neurology

Comparison of valproic acid and phenytoin in newly diagnosed tonic-clonic seizures

B. J. Wilder, MD, R. Eugene Ramsay, MD, Jerome V. Murphy, MD, Barry J. Karas, PharmD, Kathleen Marquardt, RN and Edward J. Hammond, PhD

Neurology and Medical Research Service, Veterans Administration Medical Center, Department of Neurology, University of Florida College of Medicine, Gainesville, FL (Drs. Wilder, Karas, and Hammond); Neurology and Medical Research Service, Veterans Administration Medical Center and University of Miami School of Medicine, Miami, FL (Dr. Ramsay); and Milwaukee Pediatric Neurology, Milwaukee, WI (Dr. Murphy and Ms. Marquardt).

Sixty-one newly diagnosed epileptic patients with generalized tonic-clonic, clonic, or tonic seizures were randomly allocated to treatment with valproate (VPA) and phenytoin (PHT). After 6 months, both drugs had been effective in preventing recurrence of seizures. Seventy-three percent of patients receiving VPA and 47% of patients receiving PHT had no recurrences. Side effects of either drug were mild. Laboratory abnormalities were similar for both drugs. Except for one PHT patient with toxic hepatitis, therapy was not discontinued.

Address correspondence and reprint requests to Dr. Wilder, Chief, Neurology Service (127). Veterans Administration Medical Center, Gainesville, FL 32602.

This work was supported by the Medical Research Service of the Veterans Administration, the Epilepsy Research Foundation of Florida, Inc., and the Southern Foundation for Brain Research.

Accepted for publication March 2, 1983




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Nicolson, R E Appleton, D W Chadwick, and D F Smith
The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies
J. Neurol. Neurosurg. Psychiatry, January 1, 2004; 75(1): 75 - 79.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
J. W. Wheless
Use of Topiramate in Childhood Generalized Seizure Disorders
J Child Neurol, December 1, 2000; 15(1_suppl): S7 - S13.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by AAN Enterprises, Inc.